» Articles » PMID: 11896394

Role of Antigen Receptor Affinity in T Cell-independent Antibody Responses in Vivo

Overview
Journal Nat Immunol
Date 2002 Mar 16
PMID 11896394
Citations 157
Authors
Affiliations
Soon will be listed here.
Abstract

To examine how B cell receptor affinity affects clonal selection in thymus-independent type 2 (TI-2) immune responses, we produced mice with antibodies that showed a 40-fold difference in affinity for the hapten (4-hydroxy-3-nitrophenyl)acetyl (NP). The difference in the responses of high- and low-affinity B cells to NP-Ficoll was only twofold. However, in competition experiments only the high-affinity B cells responded to antigen. CD19 deficiency increased the affinity threshold of TI-2 responses, whereas Lyn deficiency enhanced clonal expansion but abrogated B cell terminal differentiation. Thus, in TI-2 immune responses, large differences in affinity produce only small differences in the intrinsic ability of B cells to respond to antigen, and selection for high-affinity clones is due to clonal competition during the earliest stages of the response.

Citing Articles

KLF2 expression in IgG plasma cells at their induction site regulates the migration program.

Ise W, Koike T, Shimada N, Yamamoto H, Tai Y, Shirai T J Exp Med. 2025; 222(5).

PMID: 39976598 PMC: 11841683. DOI: 10.1084/jem.20241019.


Aberrant METTL1-mediated tRNA mG modification alters B-cell responses in systemic autoimmunity in humans and mice.

Wang S, Han H, Qian Y, Ruan X, Lin Z, Li J Nat Commun. 2024; 15(1):10599.

PMID: 39638793 PMC: 11621805. DOI: 10.1038/s41467-024-54941-4.


analysis of CRISPR-edited germinal center murine B cells.

Chege Kuria T, Schneider A, Baraka F, Wanzek J, Vogg L, Brey S Front Immunol. 2024; 15:1473760.

PMID: 39483469 PMC: 11524869. DOI: 10.3389/fimmu.2024.1473760.


Synergy and antagonism in the integration of BCR and CD40 signals that control B-cell proliferation.

Huang H, Narayanan H, Hoffmann A bioRxiv. 2024; .

PMID: 39131345 PMC: 11312454. DOI: 10.1101/2024.07.28.605521.


Characterization of Turbo, a TLR Ligand-based Adjuvant for Glycoconjugate Vaccines.

Alugupalli K Immunohorizons. 2024; 8(8):527-537.

PMID: 39093309 PMC: 11374753. DOI: 10.4049/immunohorizons.2400040.